Concepedia

Author

Lawrence Zemel

Connecticut Children's Medical Center

Also Known As

D. Brautigam, L S Zemel, L Zemel, L. S. Zemel, L. Zemel, LAWRENCE S. ZEMEL, Lawrence S Zemel, Lawrence S. Zemel, Lawrence Zemel, N. Rasouli

59

Publications

5K

Citations

32

H-Index

41

Concepts

All Affiliations

Connecticut Children's Medical CenterCincinnati Children's Hospital Medical CenterHospital for Sick ChildrenUniversity of CincinnatiUniversity of Toronto
LZ

About

Lawrence Zemel is an author at Connecticut Children's Medical Center specializing in medicine, parasitology, and rheumatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

784

2

Allergy

2

2

124

3

Public Health

1

1

14

4

Cell Biology

1

1

322

5

Diabetes

1

1

94

Lawrence Zemel

×

39

Publications

4.7K

Citations

30

H-Index

YearCitations

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

Fabrizio De Benedetti, Hermine I. Brunner, Nicolino Ruperto,

New England Journal of Medicine

2012

840

Methotrexate in Resistant Juvenile Rheumatoid Arthritis

Edward H. Giannini, Earl J. Brewer, N. N. Kuzmina,

New England Journal of Medicine

1992

589

CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome

José Roberto Marcelino, John D. Carpten, Wafaa M. Suwairi,

Nature Genetics

1999

322

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease

Paul M. Lantos, Jeffrey A. Rumbaugh, Linda K. Bockenstedt,

Clinical Infectious Diseases

2020

322

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: II. The childhood myositis assessment scale (CMAS): a quantitative tool for the evaluation of muscle function

Daniel J. Lovell, Carol B. Lindsley, Robert M. Rennebohm,

Arthritis & Rheumatism

1999

238

Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies

Adam M. Huber, Brian M. Feldman, Robert M. Rennebohm,

Arthritis & Rheumatism

2004

229

Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

Norman T. Ilowite, Kristi Prather, Yuliya Lokhnygina,

Arthritis & Rheumatology

2014

158

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessments

Lisa G. Rider, Frederick W. Miller, Brian M. Feldman,

Arthritis & Rheumatism

1997

148

History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry

Lauren M. Pachman, Rebecca B. Lipton, Rosalind Ramsey‐Goldman,

Arthritis Care & Research

2005

148

Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Adam M. Huber, Jeanne E. Hicks, Peter A. Lachenbruch,

PubMed

2001

126

Page 1